Aegis Capital Notes 'Uneventful' Q3 for Aerie Pharma (AERI); Rhopressa NDA Now Expected in Jan. '17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
Go back to Aegis Capital Notes 'Uneventful' Q3 for Aerie Pharma (AERI); Rhopressa NDA Now Expected in Jan. '17
November 2, 2016 4:07 PM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
...
More
